{ "cik": 1369568, "cik_padded": "0001369568", "entityName": "CATALYST PHARMACEUTICALS, INC.", "fiscal_years": [ { "accn": "0001193125-26-197490", "filed": "2026-04-30", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 25300000.0, "capex": 58000.0, "cash": 709171000.0, "eps_diluted": 1.68, "free_cash_flow": 208612000.0, "net_income": 214326000.0, "operating_cash_flow": 208670000.0, "operating_income": 257778000.0, "revenue": 588989000.0, "stockholders_equity": 954268000.0, "total_assets": 1103979000.0, "total_liabilities": 149711000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.15688569668059707, "net_margin": 0.36388795036919197, "operating_margin": 0.4376618239050305, "revenue_growth_yoy": 0.1977796938995473, "roa_avg2y": 0.21921560404829726, "roa_period_end": 0.19413956243732897, "roe_avg2y": 0.2548617634817766, "roe_period_end": 0.22459728294357556 } }, { "accn": "0001193125-26-197490", "filed": "2026-04-30", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 0.0, "capex": 556000.0, "cash": 517553000.0, "eps_diluted": 1.31, "free_cash_flow": 239252000.0, "net_income": 163889000.0, "operating_cash_flow": 239808000.0, "operating_income": 195124000.0, "revenue": 491734000.0, "stockholders_equity": 727632000.0, "total_assets": 851411000.0, "total_liabilities": 123779000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.1701120896277239, "net_margin": 0.33328791582440914, "operating_margin": 0.39680803035787643, "revenue_growth_yoy": 0.2348796094464144, "roa_avg2y": 0.24803011672121222, "roa_period_end": 0.1924910530871694, "roe_avg2y": 0.29383610948505307, "roe_period_end": 0.2252361083624689 } }, { "accn": "0001193125-26-197490", "filed": "2026-04-30", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 0.0, "capex": 231000.0, "cash": 137636000.0, "eps_diluted": 0.63, "free_cash_flow": 143369000.0, "net_income": 71410000.0, "operating_cash_flow": 143600000.0, "operating_income": 86812000.0, "revenue": 398204000.0, "stockholders_equity": 387881000.0, "total_assets": 470114000.0, "total_liabilities": 82233000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.21200574402974107, "net_margin": 0.17933019256461513, "operating_margin": 0.21800885978041407, "revenue_growth_yoy": 0.8590029084559974, "roa_avg2y": 0.16886906676251914, "roa_period_end": 0.15189932654632707, "roe_avg2y": 0.2074961281530491, "roe_period_end": 0.18410285628839773 } }, { "accn": "0001193125-26-071525", "filed": "2026-02-25", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 6907000.0, "capex": 29000.0, "cash": 298395000.0, "eps_diluted": 0.75, "free_cash_flow": 116018000.0, "net_income": 83079000.0, "operating_cash_flow": 116047000.0, "operating_income": 101838000.0, "revenue": 214203000.0, "stockholders_equity": 300421000.0, "total_assets": 375630000.0, "total_liabilities": 75209000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.25034534869399944, "net_margin": 0.3878517107603535, "operating_margin": 0.47542751502079805, "revenue_growth_yoy": 0.5209716472701711, "roa_avg2y": 0.27087239044175426, "roa_period_end": 0.22117243031706732, "roe_avg2y": 0.3275649972794587, "roe_period_end": 0.2765419195062928 } }, { "accn": "0001193125-24-050908", "filed": "2025-02-26", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 12089000.0, "capex": 1021000.0, "cash": 171445000.0, "eps_diluted": 0.37, "free_cash_flow": 59351000.0, "net_income": 39482000.0, "operating_cash_flow": 60372000.0, "operating_income": 52385000.0, "revenue": 140833000.0, "stockholders_equity": 206831000.0, "total_assets": 237788000.0, "total_liabilities": 30957000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.14967292137058757, "net_margin": 0.28034622567154005, "operating_margin": 0.37196537743284597, "revenue_growth_yoy": 0.18274503875773684, "roa_avg2y": 0.18357658633660512, "roa_period_end": 0.16603865628206638, "roe_avg2y": 0.20977129817309506, "roe_period_end": 0.1908901470282501 } }, { "accn": "0001193125-24-050908", "filed": "2024-02-28", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 11000.0, "cash": 130237000.0, "eps_diluted": 0.71, "free_cash_flow": 45023000.0, "net_income": 74983000.0, "operating_cash_flow": 45034000.0, "operating_income": 41303000.0, "revenue": 119073000.0, "stockholders_equity": 169598000.0, "total_assets": 192354000.0, "total_liabilities": 22756000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.1341761105673416, "net_margin": 0.6297229430685378, "operating_margin": 0.3468712470501289, "revenue_growth_yoy": 0.16389068089848102, "roa_avg2y": 0.49212708565211927, "roa_period_end": 0.38981773189016083, "roe_avg2y": 0.5830080706610478, "roe_period_end": 0.4421219589853653 } }, { "accn": "0001193125-23-071299", "filed": "2023-03-15", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 19000.0, "cash": 89512000.0, "eps_diluted": 0.3, "free_cash_flow": 34593000.0, "net_income": 31875000.0, "operating_cash_flow": 34612000.0, "operating_income": 31823000.0, "revenue": 102306000.0, "stockholders_equity": 87630000.0, "total_assets": 112376230.0, "total_liabilities": 24746274.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.28239500171174253, "net_margin": 0.3115653040877368, "operating_margin": 0.3110570250034211, "roa_avg2y": 0.3688677003309776, "roa_period_end": 0.28364539369224256, "roe_avg2y": 0.46057146985514574, "roe_period_end": 0.36374529270797673 } }, { "accn": "0001193125-22-077228", "filed": "2022-03-16", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 92018.0, "cash": 16559000.0, "eps_diluted": -0.33, "free_cash_flow": -26239563.0, "net_income": -34003514.0, "operating_cash_flow": -26147545.0, "operating_income": -35295165.0, "stockholders_equity": 50785000.0, "total_assets": 60449962.0, "total_liabilities": 9666153.0 }, "period_end": "2018-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.19033480358373536, "roa_avg2y": -0.46632092817457954, "roa_period_end": -0.5625067886725884, "roe_avg2y": -0.5161870302101851, "roe_period_end": -0.669558216008664 } }, { "accn": "0001193125-21-081545", "filed": "2021-03-15", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "cash": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 57496702.0, "net_income": -18412377.0, "operating_cash_flow": -13742572.0, "operating_income": -18679636.0, "stockholders_equity": 80963812.0, "total_assets": 85387430.0, "total_liabilities": 4423618.0 }, "period_end": "2017-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.054636977814236314, "roa_avg2y": -0.2897435913777491, "roa_period_end": -0.21563334322159597, "roe_avg2y": -0.3061770554794535, "roe_period_end": -0.2274148974112039 } }, { "accn": "0001193125-19-078253", "filed": "2019-03-18", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "net_income": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 96061.0, "cash": 13893064.0, "net_income": -18072452.0, "operating_income": -19280201.0, "stockholders_equity": 39308930.0, "total_assets": 41706853.0, "total_liabilities": 2397923.0 }, "period_end": "2016-12-31", "ratio_units": { "leverage": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.06100199115061133, "roa_period_end": -0.4333209221036169, "roe_period_end": -0.45975436115915647 } }, { "accn": "0001193125-18-082292", "filed": "2018-03-14", "fiscal_year": 2015, "form": "10-K", "fundamental_units": { "capex": "USD" }, "fundamentals": { "capex": 23465.0 }, "period_end": "2015-12-31", "ratios": {} }, { "accn": "0001193125-14-104658", "filed": "2014-03-19", "fiscal_year": 2013, "form": "10-K", "fundamental_units": { "operating_cash_flow": "USD" }, "fundamentals": { "operating_cash_flow": -9875674.0 }, "period_end": "2013-12-31", "ratios": {} } ], "latest_filing": { "accn": "0001193125-26-071525", "filed": "2026-02-25", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001369568.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001369568.json" }, "ticker": "CPRX" }